home
contact us
francais
careers
corporate profile
corporate profile
business model
board of directors
officers
locations
investor relations
investor relations
press releases
financial reports
investor presentations
regulatory filings
corporate governance
stock information
events
analyst coverage
investor contact
products
overview
info for patients & healthcare professionals
once-daily tramadol
OLEPTRO
TM
DDS-06C: twice-daily tramadol-acetaminophen
DDS-06A: twice-daily acetaminophen
DDS-08B: abuse/misuse-deterrent formulation of twice-daily oxycodone-acetaminophen
DDS-04F: propofol
DDS-06E: SN-38
partners
overview
licensing and distribution partners
research and development partners
current partnerships
partnering contacts
technology
overview
INTELLITAB™
Contramid
®
Polymeric Nano-Delivery System™
media
press releases
events
financial reports
regulatory filings
investor relations
press releases
financial reports
investor presentations
regulatory filings
corporate governance
stock information
events
analyst coverage
investor contact
Stock Information
Click on symbol for quote
TSX:DDS
NASDAQ:DDSS
recent news
> News Release Sign-Up
events
8/4/2011 - 2011 Second Quarter Conference Call
click here for details
